Merck's (MRK) Suvorexant Helps People Sleep, Says FDA
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Join SI Premium – FREE
Merck's (NYSE: MRK) Suvorexant helps people sleep, said an FDA panel.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $180 at Wolfe Research
- Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
- BioNTech ends colorectal cancer mRNA therapy trial early
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
